Articles in this Issue

• 

  RNA's comeback tour

  Wednesday, August 19, 2026
  RNA’s reputation may have been forged by a pandemic, but its future will likely be determined by something far less dramatic: the steady accumulation of clinical data, regulatory milestones and, ... read more
• 

  Global by default

  Wednesday, August 26, 2026
  For many CGT companies, the U.S. has long been the default starting point for new ventures. In recent years, that model appears to be weakening, as more companies look beyond the U.S. earlier in their... read more